Hormone replacement improves hemodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women

Journal of Hypertension

Volumn 19, Issue 2, 2001, Pages 269-278

  Light, Kathleen C ^a,b,c,d   Hinderliter, Alan L ^a,b,c   West, Sheila G ^a,b,c   Grewen, Karen M ^a,b,c   Steege, John F ^a,b,c   Sherwood, Andrew ^a,b,c   Girdler, Susan S ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Blood pressure; Hormone replacement; Left ventricular mass; Postmenopausal; Stress; Vascular resistance

Indexed keywords

CONJUGATED ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CATECHOLAMINE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; HEART INDEX; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HEART PROTECTION; HEART STROKE VOLUME; HEMODYNAMICS; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR RESISTANCE;

EID: 0035143870     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200102000-00014     Document Type: Article

References (54)

1. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
2. Reduced mortality associated with long-term postmenopausal estrogen therapy
3. Postmenopausal hormone therapy and mortality
4. Hormone replacement therapy and the risk of stroke: Follow-up of a population-based cohort in Sweden
5. Postmenopausal estrogen and progestin use and risk of cardiovascular disease
6. Women's Health Initiative: Why now? What is it? What's new?
7. Estrogen and coronary heart disease in women
8. The effects of hormone replacement therapy in normal postmenopausal women: Measurements of Doppler-derived parameters of aortic flow
9. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause
10. A double-blind, placebo controlled study of postmenopausal oestregen replacement therapy and carotid artery pulsatility index
11. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms
12. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
13. Acute vascular effects of estrogen in postmenopausal women
14. Variations of cardiac performance and inotropism in healthy postmenopausal women treated with estroprogestin
15. Exercise echocardiography in postmenopausal hormone users with mild systemic hypertension
16. Effect of hormone replacement on non-invasive cardiovascular hemodynamics
17. Hormonal therapy increases arterial compliance in postmenopausal women
18. Racial differences in left ventricular structure in healthy young adults
19. Contrast in cardiac anatomy between black and white patients with essential hypertension
20. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
21. Effect of hormone replacement therapy on left ventricular hypertrophy
22. The effect of hormone replacement on diastolic left ventricular function in hypertensive and normotensive postmenopausal women
23. Effect of short-term hormone replacement therapy on left ventricular mass and contractile function
24. Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: A randomized, double-blind, placebo controlled, crossover trial
25. Premenopausal and postmenopausal women differ in cardiovascular and neuroendocrine responses to behavioral stressors
26. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen
27. Acute estradiol and progesterone administration reduces cardiovascular and catecholamine responses to mental stress in menopausal women
28. Effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors
29. Use of menopausal estrogens and medroxypregesterone in the United States, 1982-1992
30. Effects of hormone replacement therapy on reactivity of atherosclerotic arteries in cynomolgous monkeys
31. The HERS Trial results: Paradigms lost?
32. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
33. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women
34. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women
35. A metaanalysis of three decades of validating impedance cardiography
36. Physiological determinants of hyperreactivity to stress in borderline hypertension
37. Committee Report: Methodological guidelines for impedance cardiography
38. Cardiac output can be reliably measured non-invasively after coronary artery bypass grafting operation
39. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
40. Echocardiographic assessment of left ventricular hypertrophy: Comparison of necropsy findings
41. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight
42. Ambulatory-not office-brood pressures decline during hormone replacement therapy in healthy postmenopausal women
43. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women
44. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women
45. The rote of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
46. Estrogen-induced increases in coronary blood flow are antagonized by inhibitors of nitric oxide synthesis
47. Mechanism of increased alpha-adrenergic vasoconstriction in human essential hypertension
48. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension
49. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women
50. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women
51. Sympathetic hyperactivity and coronary risk in hypertension
52. Should echocardiography be performed to assess effects of antihypertensive therapy? Testretest reliability of echocardiography for measurement of left ventricular mass and function
53. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
54. Effects of estrogen replacement on the progression of coronary artery atheroscleresis